Acute response to rapid iloprost inhalation using the Breelib™ nebulizer in pulmonary arterial hypertension: the Breelib™ acute study

PVRI Member Authors: Manuel Richter, Ardeschir Ghofrani, Werner Seeger

The Breelib™ nebulizer was designed to reduce iloprost inhalation times for patients with pulmonary arterial hypertension (PAH). In 30 patients with PAH, rapid inhalation of iloprost 2.5 µg using Breelib™ caused significant improvements in invasively measured afterload and cardiac index but not echocardiographic right ventricular strain during 30 min post-inhalation.

Read the full article online


Pulmonary Hypertension
Right Ventricle: Structure, Function and Dysfunction


Manuel J. Richter, Jun Wan, Hossein A. Ghofrani, Werner Seeger, Henning Gall, Andreas Rieth Khodr Tello

Published in:

Pulmonary Circulation Vol 9: No 3 cover image

September 2019

Pulmonary Circulation Vol 9: No 3

View this journal

Our research platform is the world.

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI